Clinical Trial Update: Stress Reduction and Atherosclerotic CVD in Blacks [Phase 3]

View source ↗

Summary

Phase 3 trial studying stress reduction in atherosclerotic cardiovascular disease among Black participants has completed. The update notes completion of the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Cardiovascular Disease
• Coronary Artery Disease
• Heart Disease
• Hypertension
• Vascular Disease

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Heart Diseases | Phase 3 | Status: COMPLETED